This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress

NETWORKING BEGINS IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Catherine Gray, PharmD
PharmD, Director, Office of Prescription Drug Promotion at US Food and Drug Administration (FDA)
Speaker

Profile

Catherine Gray leads the Office of Prescription Drug Promotion (OPDP) in the Office of Medical Policy (OMP) at the FDA. Her diverse team of professionals focuses on the challenging and evolving policy and operational issues pertaining to prescription drug promotion. She oversees policy development, social science research, regulatory counseling, compliance activities, labeling development, stakeholder engagement, and operational support to the office as it realizes its mission to protect the public health. She previously worked in clinical pharmacy and the pharmaceutical industry. Dr. Gray’s education includes a B.S. from the University of Notre Dame, a Doctor of Pharmacy from Campbell University, and fellowships through Rutgers University and the Partnership for Public Service.

Agenda Sessions

  • FDA Address

    11:00am